Efficacy of on‐demand treatment in reducing morbidity in patients with hereditary angioedema due to C1 inhibitor deficiency

Publisher： John Wiley & Sons Inc

E-ISSN： 1398-9995|70|12|1553-1558

ISSN： 0105-4538

Source： ALLERGY, Vol.70, Iss.12, 2015-12, pp. : 1553-1558

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ecallantide for the treatment of acute attacks of hereditary angioedema due to C1-inhibitor deficiency

By Bernstein Jonathan A   Biedenkapp Joseph  

Clinical Investigation, Vol. 3, Iss. 9, 2013-09 ,pp. : 859-873

Future Science

Access to resources Recommend Favorite

Hereditary Angioedema: Long-Term Treatment with One or More Injections of C1 Inhibitor Concentrate per Week

By  

International Archives of Allergy and Immunology, Vol. 154, Iss. 1, 2010-07 ,pp. : 81-88

Karger

Access to resources Recommend Favorite

Long-Term Prophylaxis of Hereditary Angioedema with a Pasteurized C1 Inhibitor Concentrate

By  

International Archives of Allergy and Immunology, Vol. 154, Iss. 4, 2010-10 ,pp. : 356-359

Karger

Access to resources Recommend Favorite

Phase II study results of a replacement therapy for hereditary angioedema with subcutaneous C1‐inhibitor concentrate

By  

ALLERGY, Vol. 105-4538, Iss. 10, 2015-10 ,pp. : 1319-1328

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase II study results of a replacement therapy for hereditary angioedema with subcutaneous C1‐inhibitor concentrate

By  

ALLERGY, Vol. 70, Iss. 10, 2015-10 ,pp. : 1319-1328

John Wiley & Sons Inc

Access to resources Recommend Favorite